RGT fundamentals
An in-depth look to ARGENT BIOPHARMA LIMITED operating, investing, and financing activities
RGT free cash flow for H2 24 is -6.88 M AUD. For 2024, RGT free cash flow was -14.8 M AUD and operating cash flow was -14.66 M AUD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
TTM